BUCCIONI, Michela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.368
EU - Europa 5.873
AS - Asia 3.573
SA - Sud America 506
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 9
Totale 21.435
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.050
CN - Cina 1.562
RU - Federazione Russa 1.290
PL - Polonia 1.266
SG - Singapore 1.016
IT - Italia 977
DE - Germania 670
BR - Brasile 421
GB - Regno Unito 335
UA - Ucraina 325
HK - Hong Kong 313
CA - Canada 272
SE - Svezia 267
FR - Francia 250
FI - Finlandia 181
KR - Corea 147
VN - Vietnam 134
TR - Turchia 129
IE - Irlanda 80
IN - India 67
BE - Belgio 53
JP - Giappone 52
AR - Argentina 43
MX - Messico 33
EU - Europa 31
NL - Olanda 31
ZA - Sudafrica 31
ES - Italia 25
BD - Bangladesh 24
CZ - Repubblica Ceca 23
AT - Austria 21
IR - Iran 19
RO - Romania 16
EC - Ecuador 14
AE - Emirati Arabi Uniti 13
PK - Pakistan 12
TW - Taiwan 11
RS - Serbia 10
CH - Svizzera 9
LT - Lituania 9
TN - Tunisia 9
PE - Perù 8
AZ - Azerbaigian 7
ID - Indonesia 7
IL - Israele 7
KE - Kenya 7
AU - Australia 6
EG - Egitto 6
IQ - Iraq 6
MA - Marocco 6
PY - Paraguay 6
UZ - Uzbekistan 6
AM - Armenia 5
BG - Bulgaria 5
CL - Cile 5
DK - Danimarca 5
JO - Giordania 5
LB - Libano 5
SA - Arabia Saudita 5
BY - Bielorussia 4
CO - Colombia 4
DZ - Algeria 4
GE - Georgia 4
HR - Croazia 4
AL - Albania 3
GR - Grecia 3
HN - Honduras 3
NO - Norvegia 3
PH - Filippine 3
VE - Venezuela 3
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KH - Cambogia 2
KW - Kuwait 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AS - Samoa Americane 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
GM - Gambi 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KI - Kiribati 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
MW - Malawi 1
Totale 21.427
Salva come PNG Salva come JPEG
Città #
Fairfield 1.156
Warsaw 1.027
Woodbridge 977
Ashburn 851
Dallas 803
Jacksonville 759
Houston 633
Chandler 592
Seattle 482
Wilmington 468
Ann Arbor 443
Singapore 439
Cambridge 417
Boardman 338
Hong Kong 298
Camerino 251
Beijing 236
Kraków 229
Nanjing 211
Toronto 189
Los Angeles 181
The Dalles 149
New York 128
Seoul 124
Tongling 113
Columbus 112
San Mateo 112
Lawrence 107
Princeton 107
Dearborn 105
Istanbul 104
Ogden 96
Nanchang 84
Moscow 82
Dublin 79
Düsseldorf 79
London 78
Buffalo 77
Helsinki 76
Shanghai 74
San Diego 68
Munich 65
Lachine 64
Milan 58
Chicago 57
Guangzhou 55
Brussels 51
Kunming 50
São Paulo 50
Santa Clara 45
Council Bluffs 44
Ho Chi Minh City 42
Shenyang 42
Tokyo 38
Tianjin 36
Centro 33
Jiaxing 33
Rome 30
Hebei 29
Frankfurt am Main 28
Hefei 28
Philadelphia 28
Wuhan 28
Dong Ket 27
Orem 27
Hangzhou 26
Brooklyn 23
Ningbo 23
Hanoi 22
Changsha 21
Denver 21
Norwalk 21
San Francisco 21
Jinan 20
Redwood City 20
Chennai 19
Johannesburg 19
Nuremberg 19
Poplar 19
Boston 18
Turku 18
Atlanta 17
Bremen 17
Phoenix 17
Falls Church 16
Venezia 16
Brno 15
Redondo Beach 15
Rio de Janeiro 15
Tampa 15
Verona 15
Orange 13
Mexico City 12
Nürnberg 12
Zhengzhou 12
Belo Horizonte 11
Manchester 11
Perugia 11
Scafati 11
Stockholm 11
Totale 14.514
Salva come PNG Salva come JPEG
Nome #
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: Structure-affinity/activity relationship at α1-adrenoceptor subtypes and at 5-HT1A receptors. 579
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands 558
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 492
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 404
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 382
Overview on Radiolabel-Free in Vitro Assays for GPCRs 378
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 353
Pharmacological characterization of the GPR17 receptor dual profile 352
The G Protein-Coupled Receptor GPR17: Overview and Update 323
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 323
Blue honeysuckle fruit (Lonicera caerulea L.) from eastern Russia: phenolic composition, nutritional value and biological activities of its polar extracts 311
GPR17 receptor modulators and their therapeutic implications: review of recent patents 276
8-(2-Furyl)adenine derivatives as A2A adenosine receptor ligands 270
Polar extracts from the berry-like fruits of Hypericum androsaemum L. as a promising ingredient in skin care formulations 267
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 261
Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol: novel M4 muscarinic receptor antagonists 259
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 254
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 251
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 250
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 248
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 243
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 235
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 231
Synthesis and alpha1-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin 229
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 224
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines 221
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 212
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 211
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 211
Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor 211
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 209
New sensible method to quantize the intestinal absorption of receptor ligands 208
Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 207
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A(2A) and A(2B) receptors ligands 206
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 205
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 200
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 200
(+)-Cyclazosin derivatives as α1-adrenoceptor antagonists 199
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 198
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 195
(+)-Cyclazosin, a selective alpha1B-adrenoceptor antagonist: Functional evaluation in rat and rabbit tissues 194
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 194
Analogues of Prazosin That Bear a Benextramine-Related Polyamine Backbone Exhibit Different Antagonism toward alpha1-Adrenoceptor Subtypes 193
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives 192
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 192
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 192
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 191
Deoxamuscaroneoxime Devatives as useful Muscarinic Aginist to Explore the Muscarinic Subsite: Demox, Amodulator of Orthosteric and Allosteric Site at Cardiac Muscarinic M2 Receptors. 190
Discovery of a new series of 5-HT1A receptor agonists 189
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 188
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 188
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 188
Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonist 188
Structure-Activity Relatioships Among Novel Phenoxybenzamine-Related Beta-Chloroethylamines. 186
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor 186
Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol 184
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 183
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: The discovery of new functionally selective muscarinic agonists 176
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure 175
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 175
Molecular modulation of muscarinic antagonists. Synthesis and affinity profile of 2,2-diphenyl-2-ethylthio-acetic acid esters designed to probe the binding site cavity. 174
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer. 170
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 168
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 166
Highly chiral muscarinic ligands: The discovery of (2S,2 ' R,3 ' S,5 ' R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M-2 partial agonist 164
Polyamines may modulate both G protein-coupled receptors and G proteins. 162
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity 162
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 160
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 159
Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4 chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation 158
Structure-activity relationships among novel phenoxybenzamine-related beta-chloroethylamines 153
Synthesis and cholinergic affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine, 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of their iodomethylates. 152
Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists 152
High affinity ligands and potent antagonists for the α1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives 151
Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl) pyrrolidine sulfoxide derivatives 151
null 149
Outstanding insecticidal activity and sublethal effects of Carlina acaulis root essential oil on the housefly, Musca domestica, with insights on its toxicity on human cells 148
Functional cAMP assay optimization at CHO cells expressing A2A adenosine receptors and stably transfected with firefly luciferase biosensor 144
New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: High affinity ligands for the alpha-adrenoceptor subtypes 142
In vitro metabolism studies of new adenosine A(2A) receptor antagonists 141
Purinergic P2X receptors: Structural models and analysis of receptor-ligand interaction 141
New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases 141
(+)-Cyclazosin Derivatives as alpha1-Adrenoceptor Antagonists 139
Synthesis and α(1)-adrenoceptor antagonist activity of tamsulosin analogues 138
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? 137
Structure-Activity Relationships in 2,2-Diphenyl-2-ethylthioacetic Acid Esters: Unexpected Agonist Activity in a Series of Muscarinic Antagonists. 130
Existence of snoRNA, microRNA, piRNA characteristics in a novel non-coding RNA: x-ncRNA and its biological implication in Homo sapiens 128
New purine derivatives as P2X3 receptor antagonists 128
Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A(3) receptor 128
Structure–activity relationships of methoctramine-relatedpolyamines as muscarinic antagonist: Effect of replacing theinner polymethylene chain with cyclic moieties 127
Development of new chromatographic tools based on Adenosine A2A subtype receptor for ligand characterization and screening by FAC-MS 125
GTP-Eu binding assay optimization for the adenosine A3 receptor ligands screening 124
Butter oil (ghee) enrichment with aromatic plants: Chemical characterization and effects on fibroblast migration in an in-vitro wound healing model 122
Anticancer activity study of A3 adenosine receptor agonists 120
A2A adenosine receptor ligands: effects on alcohol intake in alcohol-preferring rats 119
New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists 118
“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies 116
Adenosine A2A Receptor Antagonists: Chemistry, SARs, and Therapeutic Potential 112
New 9-methyl-8-(4-hydroxyphenyl)adenine derivatives as A(1) adenosine receptor antagonists 111
Identification of putative guanosine receptor in rat brain 111
Totale 20.431
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.449
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.920 0 0 0 0 0 292 530 85 247 173 364 229
2021/20221.424 136 347 40 55 64 48 84 112 105 148 130 155
2022/20231.496 171 93 60 246 149 193 10 98 240 73 120 43
2023/20241.239 161 65 73 49 46 108 63 95 139 43 49 348
2024/20254.005 149 86 334 191 134 220 453 1.037 303 270 291 537
2025/20263.598 382 413 1.136 829 722 116 0 0 0 0 0 0
Totale 21.855